Collagen is a type of connective tissue found in skin, bone, tendon, cartilage, synovium, the walls of blood vessels and the outer covering of nerves. The mast cell is an immune sentinel or "guard" that originates from stem cells in the bone marrow. It is found abundantly in the skin, respiratory tract, gastrointestinal and genitourinary tracts, but can also be found in clusters next to small blood vessels, the nervous system, and in loose connective tissue where Lyme likes to hide (see above). The purpose of a mast cell is to alert the immune system to outside invaders (wounds, bacteria, viruses, bee stings, allergens, etc). The surface of the mast cell is covered with IgE receptors which are very sensitive to allergens and parasites. When a foreign antigen comes into contact with the mast cell it will trigger the release of the contents of the mast cell. One of the contents is histamine, a powerful vasodilator which affects vascular permeability, smooth-muscle contraction, and secretion of certain mucosal cells.
Over time, women may also develop uterine abnormalities such as uterine fibroids, endometrial polyps, and uterine scarring. Uterine fibroids are benign tumors that can grow in areas of the uterus that could prevent implantation of an embryo. Endometrial polyps result from an overgrowth of the tissue that lines the uterus; they too can interfere with the implantation of an embryo. These can be treated with a minor surgery call hysteroscopy. Recurrent pregnancy loss: Recurrent pregnancy loss is defined as two or more consecutive pregnancy losses. Most times a pregnancy loss is a result of chromosomal abnormalities in the embryo, but there are other factors that can contribute to pregnancy loss. Besides genetic/chromosomal factors, other factors associated with recurrent pregnancy losses included anatomical defects of the uterus, immunological causes and thrombophilia (predisposition to forming blood clots). It is important that a couple with more than two consecutive pregnancy losses consult with a fertility specialist before attempting a third pregnancy. Infection: Pelvic inflammatory disease (PID) is an infection and can affect the uterus, fallopian tubes and/or the ovaries and can impact fertility. It can lead to pelvic adhesions and scar tissue that develops between internal organs, causing ongoing pelvic pain and the possibility of an ectopic pregnancy (when a fertilized egg becomes implanted outside the uterus). The most common causes of PID are the sexually transmitted infections gonorrhea and chlamydia. How is female infertility treated? If you suspect you are experiencing issues with your fertility or are concerned about preserving your fertility for a future pregnancy, it is highly recommended that you seek a medical consultation as soon as possible.
The Cleo Q Pelvic Toner is a device designed to treat the problems caused by a weakened pelvic floor. These might include incontinence, vaginal slackness leading to loss of sexual satisfaction and even prolapse. Using a pelvic toner can, over, time, help to repair the damage which can be as a consequence of childbirth, over-exercising or just aging. By ignoring the signs of a weakening pelvic floor, you may find that wearing expensive incontinence pads simply becomes a way of life. This Cleo Q Pelvic Toner review takes into account the inherent differences between this and other similar devices. On the face of it, you may find it difficult to choose the most suitable toner for you and it is only right that such a purchase should take careful consideration. Firstly, most electronic pelvic toners do not come cheap! However, when you compare this cost against how much many women spend on incontinence products, the figures can be staggering.
After fertilization, which typically occurs near the site of egg release, the resulting embryo will slowly travel back to the uterus-a journey that normally takes about 5 days. The fallopian tubes are lined with cells whose function is to protect and nurture eggs, sperm and embryos during their journey. At their ends, the fallopian tubes have small delicate finger-like projections (fimbriae) that draw close to, envelop, and "pick-up" the egg from the ovary at the time of ovulation. Inflammation due to Chlamydia Trachomatis or Neisseria Gonorrhea damages and often permanently destroys the specialized lining of the fallopian tube(s). In severe cases, it can result in fusion of the fimbriae, thereby blocking the ends of the tube(s) and compromising their mobility and their potential to facilitate timely passage of eggs, sperm and embryos. In cases where the ends of the fallopian tubes are blocked, pus may collect and distend the tube(s). The pus is usually absorbed over time and replaced by clear, straw-colored fluid. The resulting occluded, fluid-filled, distended, and often functionless fallopian tube(s) is referred to as a hydrosalpinx. Sexually transmitted PID almost invariably affects both fallopian tubes. PID victims, who seemingly have normal pelvic anatomy, oftentimes have internal scarring and/or adhesion. This could account for the low success rate seen with tubal reparative surgeries and the high ectopic pregnancy rate (8-15%) in PID patients who subsequently conceive.
Bolan, G.A. Sexually transmitted diseases treatment guidelines, 2015. MMWR Recomm Rep. Crossref | PubMed | Scopus (18) | Google ScholarSee all References, 9x9Soper, D.E. Pelvic inflammatory disease. Obstet Gynecol. Crossref | PubMed | Scopus (101) | Google ScholarSee all References, 10x10Ness, R.B., Soper, D.E., Holley, R.L. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) randomized trial. Am J Obstet Gynecol. Abstract | Full Text | Full Text PDF | PubMed | Scopus (265) | Google ScholarSee all References, 11x11Walker, C.K. Wiesenfeld, H. Antibiotic therapy for acute pelvic inflammatory disease: the 2006 Centers for Disease Control and Prevention sexually transmitted diseases treatment guidelines. Google ScholarSee all References Despite several guidelines recommending addition of nitroimidazoles in pelvic inflammatory disease treatment,7x7Ross, J., Judlin, P., and Nilas, L. European guidelines of the management of pelvic inflammatory disease. Int J STD AIDS. Crossref | PubMed | Scopus (25) | Google ScholarSee all References, 8x8Workowski, K.A.